Overview

Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gather information about the long-term effects and safety of treatment with Rapamune in transplant patients.
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Everolimus
Sirolimus